Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Sep 8:11:1513-1522.
doi: 10.2147/PPA.S138364. eCollection 2017.

Out-of-pocket costs and adherence to antihypertensive agents among older adults covered by the public drug insurance plan in Quebec

Affiliations

Out-of-pocket costs and adherence to antihypertensive agents among older adults covered by the public drug insurance plan in Quebec

Raymond Milan et al. Patient Prefer Adherence. .

Abstract

Objective: To evaluate the effect of patient out-of-pocket costs on adherence to antihypertensive agents (AHA) in community-dwelling older adults covered by the public drug insurance plan in Quebec.

Methods: This is a secondary analysis of data from the "Étude sur la santé des aînés" study (2005-2008) on community-dwelling older adults in Quebec aged 65 years and older (N=2,811). The final sample included 881 participants diagnosed with arterial hypertension and treated with AHA. Medication adherence was measured with the proportion of days covered over a 2-year follow-up period (<80% and ≥80%). Out-of-pocket costs for AHA, in Canadian dollars (CAD), at cohort entry were categorized as follows: $0, $0.01-$5.00, $5.01-$10.00, $10.01-$15.00 and $15.01-$36.00. Multivariable logistic regression models were constructed to study adherence to AHA as a function of out-of-pocket costs while controlling for several confounders. Models were also stratified by annual household income (<$15,000 CAD and ≥$15,000 CAD).

Results: In this study, 80.8% of participants were adherent to their AHA. Among participants reporting an annual household income <$15,000 CAD, those with an out-of-pocket cost of $10.01-$15.00 CAD were significantly less adherent to their AHA than those with no contribution (OR =0.175, 95% CI: 0.042-0.740). Among participants reporting an income of ≥$15,000 CAD, those with out-of-pocket costs of $0.01-$5.00 CAD (OR =0.194; 95% CI: 0.048-0.787), $5.01-$10.00 CAD (OR =0.146; 95% CI: 0.036-0.589), $10.01-$15.00 CAD (OR =0.192; 95% CI: 0.047-0.777) and $15.01-$36.00 CAD (OR =0.160, 95% CI: 0.039-0.655) were significantly less adherent to their AHA than participants with no contribution.

Conclusion: Increased out-of-pocket costs are associated with non-adherence to AHA in older adults covered by a public drug insurance plan, more importantly in those reporting an annual household income ≥$15,000 CAD. A reduction in the amount of out-of-pocket costs and yearly maximum contribution for drugs may improve adherence to treatment.

Keywords: hypertension; income; medication adherence; out-of-pocket costs; seniors.

PubMed Disclaimer

Conflict of interest statement

Disclosure HMV is a Senior research scholar with the FRQS. RM received a scholarship from the Faculty of Medicine and Health Sciences of Université de Sherbrooke. SGG holds a Doctoral Award – Frederick Banting and Charles Best Canada Graduate Scholarships (CGS–D) from CIHR (number: 146258). The authors report no other conflicts of interest in this work.

Figures

Figure 1
Figure 1
Study flow chart. Abbreviations: AHA, antihypertensive agents; ESA, “Étude sur la santé des aînés”; MED-ECHO, “Maintenance et exploitation des données pour l’étude de la clientèle hôspitalière” [Database on hospitalizations]; MMSE, mini-mental state examination; RAMQ, “Régie de l’Assurance Maladie du Québec” [Quebec’s medical insurance plan].
Figure 2
Figure 2
Time frame for data collection for each participant. Note: aThe baseline interviews (T1) were conducted between February 27, 2005 and November 22, 2007. T2 represented as second interviews. Abbreviations: ICD-9/10, International Classification of Diseases, 9th or 10th Edition; PDC, proportion of days covered.

Similar articles

Cited by

References

    1. Statistics Canada The 10 leading causes of death. 2011. [Accessed February 9, 2017]. Available from: http://www.statcan.gc.ca/pub/82-625-x/2014001/article/11896-eng.htm.
    1. Public Health Agency of Canada Report from the Canadian Chronic Disease Surveillance System: Hypertension in Canada. 2010. [Accessed February 9, 2017]. Available from: http://www.phac-aspc.gc.ca/cd-mc/cvd-mcv/ccdss-snsmc-2010/pdf/CCDSS_HTN_....
    1. Ho PM, Bryson CL, Rumsfeld JS. Medication adherence: its importance in cardiovascular outcomes. Circulation. 2009;119(23):3028–3035. - PubMed
    1. Padwal R, Straus SE, McAlister FA. Evidence based management of hypertension. Cardiovascular risk factors and their effects on the decision to treat hypertension: evidence based review. BMJ. 2001;322(7292):977–980. - PMC - PubMed
    1. Savage PJ, Pressel SL, Curb JD, et al. Influence of long-term, low-dose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension: The Systolic Hypertension in the Elderly Program. SHEP Cooperative Research Group. Arch Intern Med. 1998;158(7):741–751. - PubMed

LinkOut - more resources